Kezar Life Sciences, Inc.KZRNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
4.19
↑ 104% above average
Average (8y)
-98.62
Historical baseline
Range
High:448.07
Low:-1326.11
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 4.19 | -88.6% |
| 2023 | 36.63 | -79.2% |
| 2022 | 175.74 | -60.8% |
| 2021 | 448.07 | +175.0% |
| 2020 | 162.93 | +66.2% |
| 2019 | 98.05 | -76.2% |
| 2018 | 412.66 | +145.9% |
| 2017 | -899.73 | +32.2% |
| 2016 | -1326.11 | - |